A significant breakthrough in cancer investigation is arising with the use of nanobodies to reactivate mutated p53. This crucial tumor suppressor protein is frequently disabled in various kinds of cancer, causing https://extrabookmarking.com/story21948465/mini-antibodies-reactivate-tumor-suppressor-p53-the-potential-hope-for-cancer-management